Jianmin Pharmaceutical Group Co Ltd - Class A

SHSE:600976 (China)   Class A
Â¥ 55.64 (+0.63%) Apr 26
16.32
P/B:
3.63
Market Cap:
Â¥ 8.54B ($ 1.18B)
Enterprise V:
Â¥ 7.71B ($ 1.06B)
Volume:
2.03M
Avg Vol (2M):
2.35M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Jianmin Pharmaceutical Group Co Ltd ( SHSE:600976 ) from 2004 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Jianmin Pharmaceutical Group stock (SHSE:600976) PE ratio as of Apr 27 2024 is 16.32. More Details

Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) PE Ratio (TTM) Chart

To

Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) PE Ratio (TTM) Historical Data

Total 1177
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Jianmin Pharmaceutical Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-27 16.3 2024-02-23 16.6
2024-04-26 16.3 2024-02-22 16.4
2024-04-25 16.6 2024-02-21 16.3
2024-04-24 16.5 2024-02-20 15.9
2024-04-23 16.6 2024-02-19 15.8
2024-04-22 15.9 2024-02-16 16.1
2024-04-19 16.6 2024-02-09 16.1
2024-04-18 16.1 2024-02-08 16.1
2024-04-17 15.9 2024-02-07 15.9
2024-04-16 15.8 2024-02-06 14.5
2024-04-15 16.4 2024-02-05 13.2
2024-04-12 15.9 2024-02-02 13.5
2024-04-11 16.3 2024-02-01 13.8
2024-04-10 16.4 2024-01-31 14.1
2024-04-09 16.8 2024-01-30 14.8
2024-04-08 16.6 2024-01-29 15.6
2024-04-05 17.0 2024-01-26 15.2
2024-04-03 17.0 2024-01-25 16.2
2024-04-02 17.2 2024-01-24 15.6
2024-04-01 17.5 2024-01-23 16.0
2024-03-29 16.9 2024-01-22 15.9
2024-03-28 16.8 2024-01-19 16.7
2024-03-27 16.4 2024-01-18 16.5
2024-03-26 15.5 2024-01-17 16.8
2024-03-25 15.6 2024-01-16 17.4
2024-03-22 15.7 2024-01-15 17.6
2024-03-21 16.0 2024-01-12 17.6
2024-03-20 16.2 2024-01-11 18.0
2024-03-19 16.1 2024-01-10 18.3
2024-03-18 16.6 2024-01-09 18.5
2024-03-15 17.0 2024-01-08 18.6
2024-03-14 17.0 2024-01-05 19.3
2024-03-13 16.9 2024-01-04 19.8
2024-03-12 16.8 2024-01-03 19.6
2024-03-11 15.9 2024-01-02 19.3
2024-03-08 15.7 2023-12-29 19.1
2024-03-07 15.5 2023-12-28 18.9
2024-03-06 16.0 2023-12-27 19.3
2024-03-05 16.2 2023-12-26 19.1
2024-03-04 16.6 2023-12-25 19.2
2024-03-01 16.4 2023-12-22 19.8
2024-02-29 16.4 2023-12-21 21.3
2024-02-28 16.1 2023-12-20 20.6
2024-02-27 16.9 2023-12-19 21.2
2024-02-26 16.7 2023-12-18 21.5

Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Jianmin Pharmaceutical Group Co Ltd
NAICS : 325411 SIC : 2834
ISIN : CNE000001HB7

Share Class Description:

SHSE:600976: Class A
Description
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.